Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Impact of clinical trials on the use of beta-blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate
[external].
1994 (English)In: Clinical Cardiology, ISSN 0160-9289, E-ISSN 1932-8737, Vol. 17, no 6, 311-316 p.Article in journal (Refereed)
Abstract [en]

Based on selected patient populations, several randomized trials have shown beta blockers to decrease mortality after acute myocardial infarction (AMI). The purpose of this study was to describe the use of beta blockers in various subsets of patients admitted to Sahlgren's Hospital between February 15, 1986, and November 9, 1987, with AMI, and the relation of AMI to other risk indicators for death and to a 1-year mortality rate. Beta blockers, mainly metoprolol, were prescribed for 66% of all survivors at discharge. They were more frequently prescribed for younger patients and for those with a previous history of AMI and hypertension, but less frequently for those with a history of congestive heart failure and diabetes mellitus. Patients for whom beta blockers were not prescribed had a 1-year mortality of 27% versus 11% for the rest (p < 0.001). Independent predictors of 1 -year mortality after discharge were age (p < 0.001 ), history of hypertension (p < 0.001 ), prescription of beta blockers at discharge (p < 0.001 ), congestive heart failure during hospitalization (p < 0.001), and a history of AMI (p < 0.01 ). P values were corrected for baseline differences. Beta blockers were not prescribed at discharge for one-third of survivors after AMI. This group had a very high mortality during the first year. When simultaneously considering various risk indicators for death, prescription of beta blockers at discharge was associated with an increased rate of survival.

Place, publisher, year, edition, pages
John Wiley & Sons, Inc. , 1994. Vol. 17, no 6, 311-316 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:hb:diva-7746DOI: 10.1002/clc.4960170608Local ID: 2320/8601OAI: oai:DiVA.org:hb-7746DiVA: diva2:888627
Available from: 2015-12-22 Created: 2015-12-22

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Herlitz, Johan
In the same journal
Clinical Cardiology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 36 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf